Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.19
-0.35 (-3.32%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Climb Bio Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Deutsche Bank
Deutsche Bank
Buy
Initiates
$28
BuyInitiates$28+174.78%Oct 20, 2026
RBC Capital
RBC Capital
Buy
Maintains
$23
BuyMaintains$23+125.71%Oct 13, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$30
BuyReiterates$30+194.41%Oct 12, 2026
BTIG
BTIG
Buy
Maintains
$32
BuyMaintains$32+214.03%Oct 2, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aSep 4, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$26 → $30
BuyMaintains$26 → $30+194.41%Sep 4, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$21 → $25
BuyMaintains$21 → $25+145.34%Sep 3, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$23 → $40
BuyMaintains$23 → $40+292.54%Sep 3, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.